Skip to content
Home/Companies/Pharma/Nuvisan

Nuvisan

Pharma·Germany·Exited 2014·Held 4yr
Entry
2010
Hold
4yr
Exit
2014

Who owns Nuvisan?

Nuvisan was owned by ADCURAM Group through ADCURAM Group Holding (2003 vintage) from 2010 to 2014, exited via Secondary.

Buyer identity available on Pro.

Hand-verified · updated 2026-07-03

ADCURAM Group
Investor
ADCURAM Group
ADCURAM Group Holding · 2003 · Evergreen

Key facts

HQGermany
SectorPharma
StatusAcquired
Exit Type
Secondary
Buyer
MOIC
–
Exit Year
2014

More from ADCURAM Group Holding

Other portfolio companies in the same fund.

Danhaus
Danhaus
Active
ConsumerGermany· 2021
Korte Einrichtungen
Korte Einrichtungen
Active
ConsumerGermany· 2021
Schwabenhaus
Schwabenhaus
Active
ConsumerGermany· 2021
Streif
Streif
Active
ConsumerGermany· 2021
Garbe-Gruppe
Garbe-Gruppe
Exited 2023
Business ServicesGermany· 2019
to
Steinel-Gruppe
Steinel-Gruppe
Active
ConstructionGermany· 2019

More PE-backed in Pharma

Comparable pharma deals from other GPs.

Advantice Health
Advantice Health
Active
TA AssociatesUS
Alvogen
Alvogen
Active
CVC Capital Partners
CANbridge
CANbridge
Active
General AtlanticChina
Ceva
Ceva
Exited 2025
iXO Private EquityFrance
to
curia
curia
Active
The Carlyle GroupUS
Ideal Cures Pvt. Ltd.
Ideal Cures Pvt. Ltd.
Active
TA AssociatesIndia
Track Nuvisan

Save this record to your watchlist and pick up your research where you left off. No spam.

Create free account

Who could buy Nuvisan?

6 strategic and 114financial buyers match this company's sector and geography profile, ranked from verified European deal history.

Find likely buyers

Get the full record on Nuvisan.

Free. No credit card. 30 seconds. Exit buyers and MOIC on Pro.

Hand-checked deal notes on this investment
Save this company to your watchlist
Exit buyer and MOIC on this deal (Pro)
or
Continue with email

Already a member? Sign in

Look up another firm or company
Data refreshed weekly · Sourced from public filings · Report an issue